Neurodegenerative Diseases International: A Star Is Born

Authors

Author Biography

  • Santiago Perez-Lloret, Pontifical Catholic University of Argentina, National Research Council, Buenos Aires, Argentina

    Santiago Perez-Lloret is a leading expert in neurophysiology and neuropharmacology, with more than 130 papers published in international medical journals (Scopus H-index=35). He is an Associate Editor of the Frontiers in Pharmacology, BMC Neurology, and Neurodegenerative Diseases International. He has recently edited the book “Clinical Trials in Parkinson’s Disease” (Springer-Verlag). After obtaining his MD and Ph.D. at the University of Buenos Aires, he pursued master’s courses in pharmacoepidemiology, clinical pharmacology, and biostatistics at the Universities of Toulouse, Bordeaux, and Paris (France). Dr. Perez-Lloret is an Assistant professor of Neurophysiology at the Medicine School of the Buenos Aires University and a Senior Researcher at the Argentinean National Research Council. He is a member of the Education and Evidence-Based Medicine Committees of the International Parkinson’s Disease and Movement Disorder Society (MDS).

References

Müller-Nedebock AC, Dekker MCJ, Farrer MJ, Hattori N, Lim S-Y, Mellick GD, et al. Different pieces of the same puzzle: a multifaceted perspective on the complex biological basis of Parkinson’s disease. Npj Parkinsons Dis 2023;9:1–11. https://doi.org/10.1038/s41531-023-00535-8.

Hardy J, Selkoe DJ. The amyloid hypothesis of Alzheimer’s disease: progress and problems on the road to therapeutics. Science 2002;297:353–6. https://doi.org/10.1126/science.1072994.

Stefanova N, Wenning GK. Multiple system atrophy: at the crossroads of cellular, molecular and genetic mechanisms. Nat Rev Neurosci 2023;24:334–46. https://doi.org/10.1038/s41583-023-00697-7.

Cleveland DW, Rothstein JD. From Charcot to Lou Gehrig: deciphering selective motor neuron death in ALS. Nat Rev Neurosci 2001;2:806–19. https://doi.org/10.1038/35097565.

Pilo CA, Newton AC. Two sides of the same coin: protein kinase C γ in cancer and neurodegeneration. Front Cell Dev Biol 2022;10:929510. https://doi.org/10.3389/fcell.2022.929510.

Limone F, Klim JR, Mordes DA. Pluripotent stem cell strategies for rebuilding the human brain. Front Aging Neurosci 2022;14:1017299. https://doi.org/10.3389/fnagi.2022.1017299.

Santiago TC, Parra L, Nani JV, Fidalgo TM, Bradshaw NJ, Hayashi MAF. Angiotensin-converting enzymes as druggable features of psychiatric and neurodegenerative disorders. Journal of Neurochemistry 2023;166:138–55. https://doi.org/10.1111/jnc.15806.

Assogna M, Di Lorenzo F, Martorana A, Koch G. Synaptic effects of palmitoylethanolamide in neurodegenerative disorders. Biomolecules 2022;12:1161. https://doi.org/10.3390/biom12081161.

Sultana MA, Hia RA, Akinsiku O, Hegde V. Peripheral mitochondrial dysfunction: A potential contributor to the development of metabolic disorders and Alzheimer’s disease. Biology (Basel) 2023;12:1019. https://doi.org/10.3390/biology12071019.

Appel SH, Beers DR, Zhao W. Role of inflammation in neurodegenerative diseases. In: Zigmond MJ, Rowland LP, Coyle JT, editors. Neurobiology of Brain Disorders, San Diego: Academic Press; 2015, p. 380–95. https://doi.org/10.1016/B978-0-12-398270-4.00025-2.

Downloads

Published

2023-08-16

Issue

Vol. 1 No. 1 (2023)

Section

Editorial

How to Cite

Perez-Lloret, S. (2023). Neurodegenerative Diseases International: A Star Is Born. Neurodegenerative Diseases International, 1(1), 1–2. https://rasayely-journals.com/index.php/ndi/article/view/95